Table 1.
Key Findings From Surveys of Patients With NTM-PD
| Most common symptoms associated with their condition | |
| Fatigue | 77% |
| Cough productive of sputum | 71% |
| Dyspnea | 67% |
| Coughing without sputum | 51% |
| Night sweats | 49% |
| Weight loss | 43% |
| Hemoptysis | 34% |
| Lack of appetite | 33% |
| Chest pain | 32% |
| Anxiety | 32% |
| Preferences for treatment outcomes | |
| Improved quality of life | 97% |
| Increased energy/less fatigue | 84% |
| Culture conversion | 72% |
| Reduce coughing | 53% |
| Improvement in dyspnea | 42% |
| Repair lung damage | 28% |
| Improve lung function | 27% |
| Reduce progression of disease | 21% |
| Reduce mucus/sputum | 20% |
| Most common reported adverse effects of treatment | |
| Fatigue | |
| Dry mouth | |
| Cough | |
| Tinnitus | |
| Decreased appetite | |
| Dyspnea | |
| Nausea | |
| Dysphonia | |
| Cognitive dysfunction | |
| Weight loss | |
| Diarrhea |
Results from 465 respondents in a survey conducted by NTM Info & Research. NTM-PD = nontuberculous mycobacterial-pulmonary disease.